Product Name: Ibsacol
IBSacol is a globally patented fatty acid complex of cetyl myristate and cetyl palmitate that is cleaved in the gut into short chain fatty acids (SCFAs). Scientific analysis has shown SCFAs acts as prebiotics in the digestive system to rebalance the gut microbiome and have an anti-inflammatory effect in the digestive system.
IBSacol has been clinically trialled in New Zealand and the United States testing both the safety and the efficacy of the fatty acid complex. These clinical trials have shown IBSacol to significantly reduce IBS-D associated symptoms of bloating, flatulence and urgency and to decrease diarrhoea episodes. Changes in stool formation and microbiome were also found to significantly improve. IBSacol was found to be generally regarded as safe for use at the recommended daily dose.
RRP is $165 plus shipping of $20